Markets:

Overview

News

Currencies

International

Treasuries

Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

18.31 -0.50 (-2.66%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Summit Therapeutics Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 13, 2024

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...

Via Benzinga

Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference

March 05, 2024

From Summit Therapeutics Inc.

Via Business Wire

Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday ↗

February 26, 2024

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak...

Via Benzinga

Topics Stocks

Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

February 26, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Crude Oil Moves Lower; Summit Therapeutics Shares Plummet ↗

February 20, 2024

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The...

Via Benzinga

Topics Stocks

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 20, 2024

Via Benzinga

Dow Dips Over 100 Points; US Leading Economic Index Falls In January ↗

February 20, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500...

Via Benzinga

Topics Stocks

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023

February 20, 2024

From Summit Therapeutics Inc.

Via Business Wire

Summit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024

February 14, 2024

From Summit Therapeutics Inc.

Via Business Wire

Summit Therapeutics to Present at Oppenheimer’s 34th Annual Healthcare Life Sciences Conference

February 07, 2024

From Summit Therapeutics Inc.

Via Business Wire

Earnings Scheduled For February 20, 2024 ↗

February 20, 2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

Via Benzinga

Chart Of The Day: Summit Therapeutics Begins To Soar ↗

January 25, 2024

Summit Therapeutics Inc., a biopharmaceutical company, researches and develops primarily oncology therapies in the United States and the United Kingdom.

Via Talk Markets

Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 24, 2024

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares...

Via Benzinga

Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 09, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market...

Via Benzinga

Topics Stocks

Summit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference

January 08, 2024

From Summit Therapeutics Inc.

Via Business Wire

Summit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From Summit Therapeutics Inc.

Via Business Wire

Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023

November 07, 2023

From Summit Therapeutics Inc.

Via Business Wire

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

Laura Chow, MD, Cancer Immunotherapy Trailblazer, Joins Summit as Senior Vice President of Clinical Development

November 02, 2023

From Summit Therapeutics Inc.

Via Business Wire

Ivonescimab’s Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023

October 31, 2023

From Summit Therapeutics Inc.

Via Business Wire

Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday ↗

October 30, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)

October 27, 2023

Via AB Newswire

Topics Death

Summit Therapeutics to Host Q3 2023 Financial Results & Operational Progress Call on November 7, 2023

October 26, 2023

From Summit Therapeutics Inc.

Via Business Wire

H. Jack West, MD, Renowned Oncologist & Lung Cancer Expert, Joins Summit Therapeutics as Vice President of Clinical Development

October 19, 2023

From Summit Therapeutics Inc.

Via Business Wire

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday ↗

October 17, 2023

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Summit Therapeutics Appoints Proven Biotech Leader Manmeet S. Soni as Chief Operating Officer

October 16, 2023

From Summit Therapeutics Inc.

Via Business Wire

5 Meme Stocks to Sell Immediately, According to AI ↗

August 22, 2023

As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now.

Via InvestorPlace

Topics Artificial Intelligence

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal ↗

August 19, 2023

Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a...

Via Talk Markets

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

All News about Summit Therapeutics Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today